IBRX - ImmunityBio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.00
DETAILS
HIGH:
$15.00
LOW:
$12.00
MEDIAN:
$12.00
CONSENSUS:
$13.00
UPSIDE:
80.06%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 113.3 | 14.7 | 0.6 | 0.2 | 0.9 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.6 | 0.6 |
| Cost of Revenue | 0.8 | 0 | 0 | 0 | 0 | 0 | 9.0 | (3.1) | 0 | 0 | 0 | 0 | 0.3 |
| Gross Profit | 112.5 | 14.7 | 0.6 | 0.2 | 0.9 | 0.6 | (9.0) | 3.2 | 0.0 | 0.0 | 0.2 | 0.6 | 0.3 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 207.9 | 190.1 | 232.4 | 248.1 | 196.0 | 139.5 | 48.9 | 53.4 | 39.8 | 26.5 | 11.4 | 1.6 | 0.4 |
| SG&A Expenses | 147.2 | 168.8 | 129.6 | 102.7 | 135.3 | 71.3 | 9.1 | 35.5 | 53.8 | 94.4 | 226.2 | 4.3 | 2.4 |
| Other Expenses | 13.5 | 0 | 0.9 | 0.7 | 0 | 10.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 368.6 | 358.9 | 362.9 | 351.5 | 331.2 | 221.5 | 57.9 | 88.9 | 93.6 | 120.9 | 237.6 | 5.9 | 2.9 |
| Operating Income | |||||||||||||
| Operating Income | (256.0) | (344.2) | (362.2) | (351.3) | (330.3) | (220.9) | (66.9) | (98.4) | (99.1) | (124.5) | (238.9) | (6.2) | (2.3) |
| Interest Expense | 112.5 | 131.7 | 86.7 | 47.1 | 14.8 | 9.1 | 5.9 | 0.4 | 0.6 | 0.1 | 0 | 0 | 0.5 |
| Interest Income | 6.7 | 2.4 | 0.9 | 2.7 | 0.8 | 1.7 | 2.8 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Profitability | |||||||||||||
| EBITDA | (223.6) | (264.4) | (478.7) | (351.9) | (320.8) | (204.2) | (56.9) | (86.7) | (90.7) | (117.7) | (235.7) | (5.7) | (1.6) |
| EBIT | (239.1) | (282.0) | (497.2) | (370.1) | (335.0) | (217.0) | (65.9) | (96.3) | (96.3) | (121.3) | (237.2) | (5.7) | (1.6) |
| Income Before Tax | (351.6) | (413.6) | (583.9) | (417.3) | (349.8) | (226.0) | (65.9) | (96.7) | (96.9) | (121.4) | (237.2) | (6.2) | (2.0) |
| Income Tax Expense | (0.1) | 0 | (0.0) | 0.0 | 0.0 | (1.8) | (0.1) | (0.5) | (0.5) | (0.6) | (0.3) | 0.0 | 0.0 |
| Net Income | (351.4) | (413.6) | (583.2) | (416.6) | (346.8) | (221.9) | (65.8) | (96.2) | (96.4) | (120.8) | (236.9) | (6.2) | (2.0) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -0.38 | -0.59 | -1.15 | -1.04 | -0.89 | -0.59 | -0.42 | -0.30 | -0.30 | -0.37 | -0.73 | -0.02 | -0.01 |
| EPS (Diluted) | -0.38 | -0.62 | -1.15 | -1.04 | -0.89 | -0.59 | -0.42 | -0.30 | -0.30 | -0.37 | -0.73 | -0.02 | -0.01 |
| Shares Outstanding | 919.9 | 697.3 | 508.6 | 399.9 | 389.2 | 383.2 | 383.2 | 325.0 | 316.1 | 328.6 | 326.3 | 315.7 | 315.7 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 88.3 | 143.4 | 265.5 | 104.6 | 181.1 | 34.9 | 15.5 | 16.8 | 23.9 | 8.1 |
| Short-Term Investments | 154.5 | 6.4 | 1.0 | 2.5 | 136.0 | 61.1 | 36.1 | 57.3 | 104.3 | 190.8 |
| Net Receivables | 42.6 | 2.7 | 3.2 | 1.9 | 1.3 | 2.0 | 0.3 | 12.2 | 1.3 | 0 |
| Inventory | 0.9 | 8.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.9 | 1.3 | 5.2 | 2.9 | 3.0 | 0 | 0.0 | 0.0 | 0.9 | 0.7 |
| Total Current Assets | 314.9 | 184.6 | 294.1 | 140.6 | 334.3 | 111.7 | 55.8 | 88.8 | 132.5 | 205.1 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 147.5 | 170.5 | 182.7 | 189.4 | 119.2 | 90.7 | 72.2 | 76.9 | 76.7 | 19.3 |
| Goodwill | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 13.0 | 15.9 | 17.1 | 20.0 | 1.4 | 1.5 | 0 | 12.1 | 2.8 | 5.1 |
| Long-Term Investments | 10.5 | 0 | 0.9 | 0.8 | 7.6 | 11.4 | 10.9 | 14.4 | 38.3 | 87.8 |
| Other Non-Current Assets | 15.0 | 12.0 | 9.7 | 11.5 | 6.4 | 6.1 | 4.2 | (1.7) | 0.2 | 0.1 |
| Total Non-Current Assets | 187.0 | 198.3 | 210.4 | 221.8 | 134.6 | 109.7 | 87.4 | 93.2 | 118.0 | 112.4 |
| Total Assets | 501.9 | 382.9 | 504.5 | 362.4 | 468.9 | 221.4 | 143.1 | 181.9 | 250.4 | 317.5 |
| Current Liabilities | ||||||||||
| Account Payables | 7.0 | 6.7 | 9.2 | 21.0 | 11.4 | 11.5 | 1.7 | 2.8 | 5.9 | 4.0 |
| Short-Term Debt | 9.3 | 0 | 0 | 431.9 | 299.2 | 0 | 4.0 | 1.0 | 0.6 | 0.5 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0.2 |
| Other Current Liabilities | 25.4 | 16.0 | 18.3 | 19.7 | 16.5 | 18.0 | 4.8 | 23.5 | 13.9 | 7.8 |
| Total Current Liabilities | 61.8 | 54.9 | 58.3 | 500.9 | 369.0 | 68.1 | 11.6 | 27.3 | 20.9 | 12.6 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 835.2 | 461.9 | 681.5 | 241.3 | 306.3 | 254.4 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0.2 | 0.2 | 0 | 0 | 0.5 | 1.0 |
| Other Non-Current Liabilities | 70.9 | 319.4 | 310.6 | 22.1 | 0.2 | 1.0 | 0 | 2.7 | 3.4 | 2.7 |
| Total Non-Current Liabilities | 939.7 | 816.1 | 1,032.1 | 311.3 | 343.8 | 271.7 | 10.9 | 8.7 | 10.7 | 11.5 |
| Total Liabilities | 1,001.5 | 871.1 | 1,090.4 | 812.2 | 712.8 | 339.9 | 22.4 | 35.9 | 31.6 | 24.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (3,726.6) | (3,375.2) | (2,961.7) | (2,378.5) | (1,961.9) | (1,615.1) | (662.2) | (595.0) | (498.7) | (387.1) |
| Accumulated Other Comprehensive Income | 29.0 | 1.2 | 0.0 | 0.2 | 0.0 | 0.1 | (0.1) | (0.3) | (0.4) | (0.3) |
| Total Stockholders' Equity | (499.6) | (489.1) | (587.0) | (447.3) | (242.2) | (119.8) | 120.7 | 146.0 | 218.8 | 293.4 |
| Total Liabilities & Equity | 501.9 | 382.9 | 504.5 | 362.4 | 468.9 | 221.4 | 143.1 | 181.9 | 250.4 | 317.5 |
| Debt Metrics | ||||||||||
| Total Debt | 878.1 | 504.2 | 726.7 | 723.8 | 645.7 | 275.5 | 14.8 | 6.9 | 7.3 | 8.2 |
| Net Debt | 789.8 | 360.7 | 461.3 | 619.1 | 464.6 | 240.6 | (0.7) | (9.9) | (16.6) | 0.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 0 | (413.6) | (583.9) | (416.6) | (346.8) | (224.2) | (160.2) | (96.2) | (96.4) | (120.8) |
| Depreciation & Amortization | 0 | 17.6 | 18.5 | 34.5 | 14.3 | 12.7 | 14.0 | 9.6 | 5.6 | 3.6 |
| Stock-Based Compensation | 0 | 34.4 | 49.2 | 40.2 | 57.2 | 2.2 | 3.4 | 2.0 | 37.0 | 73.9 |
| Change in Working Capital | (54.3) | (19.4) | 4.0 | (16.0) | (15.4) | 16.4 | (15.6) | (0.6) | 3.2 | 3.8 |
| Other Non-Cash Items | (250.6) | (10.2) | 145.4 | 20.3 | 16.3 | 24.1 | 6.2 | 44.6 | 50.3 | 81.7 |
| Operating Cash Flow | (304.9) | (391.2) | (366.8) | (337.5) | (274.4) | (171.7) | (152.1) | (63.4) | (48.8) | (38.6) |
| Investing Activities | ||||||||||
| Capital Expenditure | (3.8) | (6.9) | (30.6) | (78.2) | (33.6) | (1.7) | (4.3) | (13.1) | (34.8) | (6.6) |
| Acquisitions | 0 | (1) | 0 | 0 | 0 | 0.0 | 0.2 | 0.4 | (0.0) | (0.1) |
| Purchases of Investments | (241.4) | (140.2) | (10.4) | 0 | 0 | (91.8) | (87.2) | (95.5) | (119.9) | (273.0) |
| Sales/Maturities of Investments | 95.8 | 136.6 | 10.5 | 0 | 0 | 73.6 | 112.3 | 165.3 | 254.2 | 165.9 |
| Other Investing Activities | 0 | (0.7) | 0 | 105.5 | (51.3) | (0.0) | (2.5) | 35.0 | 0.0 | 0.1 |
| Investing Cash Flow | (149.8) | (12.2) | (30.5) | 27.3 | (84.9) | (19.8) | 18.6 | 57.1 | 99.6 | (113.7) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 1.7 | 96.9 | 258.6 | 174.1 | 338.5 | 63.7 | 47.7 | (0.5) | (19.9) | (0.0) |
| Stock Repurchased | 0 | 0 | 0 | (0.6) | (4.1) | 0 | (2.5) | (0.2) | (15.2) | (15.8) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.3) | 73.4 | 189.6 | 60.2 | 171.0 | 0.7 | 39.1 | (0.1) | (1.0) | (1.1) |
| Financing Cash Flow | 400.2 | 281.6 | 558.3 | 233.6 | 505.4 | 150.7 | 114.3 | (0.8) | (35.0) | (15.6) |
| Cash Position | ||||||||||
| Net Change in Cash | (54.5) | (121.9) | 160.8 | (76.3) | 146.2 | (40.9) | (19.3) | (7.1) | 15.8 | (167.8) |
| Cash at Beginning | 143.9 | 265.8 | 105.0 | 181.3 | 35.1 | 76.0 | 95.3 | 23.9 | 8.1 | 175.9 |
| Cash at End | 89.4 | 143.9 | 265.8 | 105.0 | 181.3 | 35.1 | 76.0 | 16.8 | 23.9 | 8.1 |
| Free Cash Flow | (308.8) | (398.1) | (397.3) | (415.7) | (308.0) | (173.4) | (156.4) | (76.5) | (83.6) | (45.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 113.3 | 14.7 | 0.6 | 0.2 | 0.9 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.6 | 0.6 |
| Gross Profit | 112.5 | 14.7 | 0.6 | 0.2 | 0.9 | 0.6 | (9.0) | 3.2 | 0.0 | 0.0 | 0.2 | 0.6 | 0.3 |
| Operating Income | (256.0) | (344.2) | (362.2) | (351.3) | (330.3) | (220.9) | (66.9) | (98.4) | (99.1) | (124.5) | (238.9) | (6.2) | (2.3) |
| Net Income | (351.4) | (413.6) | (583.2) | (416.6) | (346.8) | (221.9) | (65.8) | (96.2) | (96.4) | (120.8) | (236.9) | (6.2) | (2.0) |
| EPS (Diluted) | -0.38 | -0.62 | -1.15 | -1.04 | -0.89 | -0.59 | -0.42 | -0.30 | -0.30 | -0.37 | -0.73 | -0.02 | -0.01 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 88.3 | 143.4 | 265.5 | 104.6 | 181.1 | 34.9 | 15.5 | 16.8 | 23.9 | 8.1 | |||
| Total Assets | 501.9 | 382.9 | 504.5 | 362.4 | 468.9 | 221.4 | 143.1 | 181.9 | 250.4 | 317.5 | |||
| Total Debt | 878.1 | 504.2 | 726.7 | 723.8 | 645.7 | 275.5 | 14.8 | 6.9 | 7.3 | 8.2 | |||
| Stockholders' Equity | (499.6) | (489.1) | (587.0) | (447.3) | (242.2) | (119.8) | 120.7 | 146.0 | 218.8 | 293.4 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (304.9) | (391.2) | (366.8) | (337.5) | (274.4) | (171.7) | (152.1) | (63.4) | (48.8) | (38.6) | |||
| Capital Expenditure | (3.8) | (6.9) | (30.6) | (78.2) | (33.6) | (1.7) | (4.3) | (13.1) | (34.8) | (6.6) | |||
| Free Cash Flow | (308.8) | (398.1) | (397.3) | (415.7) | (308.0) | (173.4) | (156.4) | (76.5) | (83.6) | (45.2) | |||